Bond Johnson & Sons 3.7% ( US478160BV55 ) in USD

Issuer	Johnson & Sons
Market price	81.804 % ▼
Country	United States
ISIN code	US478160BV55 ( in USD )
Interest rate	3.7% per year ( payment 2 times a year)
Maturity	28/02/2046
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible
Minimal amount	2 000 USD
Total amount	2 000 000 000 USD
Cusip	478160BV5
Standard & Poor's ( S&P ) rating	AAA ( Prime - Investment-grade )
Moody's rating	Aaa ( Prime - Investment-grade )
Next Coupon	01/03/2026 ( In 75 days )
Detailed description	Johnson & Johnson is a multinational corporation that manufactures and sells a wide range of healthcare products, including pharmaceuticals, medical devices, and consumer health products. A notable fixed-income opportunity is presented by a corporate bond issued by Johnson & Johnson, a globally recognized healthcare conglomerate with a diversified portfolio spanning pharmaceuticals, medical devices, and consumer health products, underscoring its long-standing market presence and financial stability. Identified by ISIN US478160BV55 and CUSIP 478160BV5, this United States-domiciled obligation is denominated in USD and currently trades at 100% of its face value. The bond offers an attractive annual interest rate of 3.7%, with coupon payments disbursed semi-annually, reflecting a payment frequency of two times per year. The total size of this particular issuance amounts to a substantial $2,000,000,000, with a minimum purchase increment set at $2,000, making it accessible to a range of institutional and qualified individual investors. This long-dated instrument is set to mature on February 28, 2046, providing a significant duration. Its exceptional credit quality is underscored by the highest possible ratings from leading agencies, holding an AAA rating from Standard & Poor's (S&P) and an Aaa rating from Moody's, indicative of superior financial strength and extremely low credit risk.